SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hyloris partner AFT Pharmaceuticals signs exclusive Japan deal for Maxigesic IV

AFT Pharmaceuticals signed an exclusive agreement with MIKASASEIYAKU to commercialize Maxigesic IV in Japan.

HYL.BR